Skip to main content
. 2022 Sep 2;27(17):5655. doi: 10.3390/molecules27175655

Figure 3.

Figure 3

Nerolidol has complex interaction with cannabinoid signaling. (A) Nerolidol (1 μM) does not alter EPSC sizes. (B) Nerolidol substantially inhibits DSE responses at 1 μM but not at 100 nM. (C) 2-AG signaling is not diminished by treatment with nerolidol. *** p < 0.001, **** p < 0.0001 at 3 and 10 s depolarizations via 2-way ANOVA with Bonferroni post hoc test.